2nd Annual Bioanalytical and Formulation Summit 2018

Topics

• Better utilizing analytical strategies for novel proteins and antibodies
• Novel bioanalytical developments for large and small molecules, peptides, and oligonucleotides
• Advanced practice in immunogenicity assessments
• Overcoming challenges presented by increased complexity and diversity of novel therapeutic modalities
• Recent experience with regulatory, and other crucial issues, affecting product quality and time to market
• Early formulation and characterization strategies

Who should Attend

• Bioassay development
• Bioanalytics
• Quality Assistance R&D
• Quality control
• Principle Scientist
• CMC
• Biophysical Analytics
• Method Development
• Analytical Development
• Characterisation Production & Analysis
• Formulation Scientist
• Preclinical Development
• Protein Biophysics & Formulation Bioanalytical Assay
• Protein Analytics
• BioFormulations
• Pharmacology
• Immunogenicity
• Researcher
• Antibody & Biologics Discovery/Development
• Biomarkers
• Molecular Biology
• Manufacturing/CMC
• Antibody Drug Conjugates (ADCs)
• Medicinal Chemistry
• Large-Molecule Drug Conjugates
• Small-Molecule Drug Conjugates
• Monoclonal Antibodies (mAbs)
• Immunoconjugates
• Clinical Development
• Target ID & Validation
• Cancer•Oncology
• Toxicology
• Antibody-Based Therapeutics
• Haematology
• Nanoparticles/Nanobodies
• Peptide-drug conjugates
• PKPD•Biotherapeutics
• Diabodies/Minibodies
• Chemotherapeutics
• Immunotherapeutics
• Rare Diseases
• Neurodegeneration Therapeutics